KBC Securities advice for IBA
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| May 10, 2017 | KBC Securities | IBA | Buy | 59.00 EUR | 72.71 % |
Advice details
Brussel - Op 10 May 2017 herhalen de analisten van KBC Securities hun koopadvies voor the Belgian biopharmaceutical company IBA (ISIN: BE0003766806 / Mnemo: IBAB). Het 12-maands koersdoel wordt neerwaarts bijgesteld van 61.0 EUR naar 59.0 EUR.
Last KBC Securities advice for IBA
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| May 10, 2017 | KBC Securities | IBA | Buy | 59.00 EUR | 72.71 % |
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 